levoleucovorin and Histiocytic-Sarcoma

levoleucovorin has been researched along with Histiocytic-Sarcoma* in 2 studies

Other Studies

2 other study(ies) available for levoleucovorin and Histiocytic-Sarcoma

Article	Year
Salvage of relapsed malignant histiocytosis by autologous bone marrow transplant. Bone marrow transplantation, 1989, Volume: 4, Issue:1 A 21-year-old female presenting with malignant histiocytosis was initially treated with conventional aggressive chemotherapy resulting in complete remission (CR) but relapsed within 6 months of discontinuation. The patient was reinduced with two cycles of cis-platinum, cytosine arabinoside and mitoxantrone and achieved CR, at which time she received single agent high-dose melphalan followed by autologous bone marrow transplant. She remains in CR 36 months after the autograft procedure. Topics: Abdominal Neoplasms; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Female; Histiocytic Sarcoma; Humans; Leucovorin; Methotrexate; Mitoxantrone; Remission Induction; Transplantation, Autologous; Vincristine	1989
[Malignant histiocytosis: study of 8 cases]. Medicina clinica, 1988, Mar-19, Volume: 90, Issue:11 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Bleomycin; Bone Marrow; Child; Cyclophosphamide; Doxorubicin; Female; Histiocytic Sarcoma; Humans; Leucovorin; Lymph Nodes; Male; Methotrexate; Microscopy, Electron; Middle Aged; Prednisone; Radiography; Vincristine	1988

Article

Year

Salvage of relapsed malignant histiocytosis by autologous bone marrow transplant.

Bone marrow transplantation, 1989, Volume: 4, Issue:1

A 21-year-old female presenting with malignant histiocytosis was initially treated with conventional aggressive chemotherapy resulting in complete remission (CR) but relapsed within 6 months of discontinuation. The patient was reinduced with two cycles of cis-platinum, cytosine arabinoside and mitoxantrone and achieved CR, at which time she received single agent high-dose melphalan followed by autologous bone marrow transplant. She remains in CR 36 months after the autograft procedure.

Topics: Abdominal Neoplasms; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Female; Histiocytic Sarcoma; Humans; Leucovorin; Methotrexate; Mitoxantrone; Remission Induction; Transplantation, Autologous; Vincristine

1989

[Malignant histiocytosis: study of 8 cases].

Medicina clinica, 1988, Mar-19, Volume: 90, Issue:11

Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Bleomycin; Bone Marrow; Child; Cyclophosphamide; Doxorubicin; Female; Histiocytic Sarcoma; Humans; Leucovorin; Lymph Nodes; Male; Methotrexate; Microscopy, Electron; Middle Aged; Prednisone; Radiography; Vincristine

1988